OGC
Oak Grove Capital’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,970
| Closed | -$473K | – | 51 |
|
|
2023
Q1 | $473K | Sell |
2,970
-69,278
| -96% | -$11M | 0.19% | 34 |
|
|
2022
Q4 | $11.7M | Sell |
72,248
-42,593
| -37% | -$6.88M | 5.87% | 5 |
|
|
2022
Q3 | $15.4M | Sell |
114,841
-3,300
| -3% | -$443K | 5.2% | 5 |
|
|
2022
Q2 | $18.1M | Sell |
118,141
-25,165
| -18% | -$3.85M | 5.88% | 4 |
|
|
2022
Q1 | $23.2M | Sell |
143,306
-2,210
| -2% | -$358K | 4.71% | 6 |
|
|
2021
Q4 | $19.7M | Sell |
145,516
-13,099
| -8% | -$1.77M | 3.43% | 8 |
|
|
2021
Q3 | $17.1M | Sell |
158,615
-1,255
| -0.8% | -$135K | 3.69% | 9 |
|
|
2021
Q2 | $18M | Buy |
159,870
+31,000
| +24% | +$3.49M | 4.03% | 5 |
|
|
2021
Q1 | $13.9M | Buy |
128,870
+34,114
| +36% | +$3.69M | 3.89% | 6 |
|
|
2020
Q4 | $10.2M | Buy |
94,756
+23,731
| +33% | +$2.54M | 3.32% | 6 |
|
|
2020
Q3 | $6.22M | Buy |
71,025
+56,657
| +394% | +$4.96M | 2.94% | 12 |
|
|
2020
Q2 | $1.41M | Sell |
14,368
-26,300
| -65% | -$2.58M | 0.85% | 26 |
|
|
2020
Q1 | $3.1M | Sell |
40,668
-2,254
| -5% | -$172K | 2% | 18 |
|
|
2019
Q4 | $3.8M | Buy |
42,922
+39,422
| +1,126% | +$3.49M | 1.48% | 23 |
|
|
2019
Q3 | $265K | Buy |
+3,500
| New | +$265K | 0.12% | 65 |
|
|
2018
Q4 | – | Sell |
-850
| Closed | -$80K | – | 56 |
|
|
2018
Q3 | $80K | Buy |
850
+350
| +70% | +$32.9K | 0.07% | 67 |
|
|
2018
Q2 | $46K | Hold |
500
| – | – | 0.05% | 68 |
|
|
2018
Q1 | $47K | Buy |
+500
| New | +$47K | 0.05% | 71 |
|